Advisor Group Holdings, Inc. Vanda Pharmaceuticals Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 468 shares of VNDA stock, worth $2,040. This represents 0.0% of its overall portfolio holdings.

Number of Shares

468

Previous 16,339 97.14%

Holding current value

$2,040

Previous $92,000 97.83%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$4.61 - $6.34 $73,165 - $100,622	-15,871 Reduced 97.14%	468 $2,000
Q2 2024 Aug 13, 2024	BUY	$3.91 - $6.5 $35,909 - $59,696	9,184 Added 128.36%	16,339 $92,000
Q1 2024 May 10, 2024	SELL	$3.47 - $4.61 $26,018 - $34,565	-7,498 Reduced 51.17%	7,155 $29,000
Q4 2023 Feb 12, 2024	BUY	$3.38 - $4.58 $14,956 - $20,266	4,425 Added 43.26%	14,653 $61,000
Q3 2023 Nov 13, 2023	BUY	$4.28 - $6.57 $13,999 - $21,490	3,271 Added 47.02%	10,228 $44,000
Q2 2023 Aug 10, 2023	BUY	$5.9 - $6.95 $3,481 - $4,100	590 Added 9.27%	6,957 $45,000
Q1 2023 May 12, 2023	BUY	$6.18 - $7.99 $11,939 - $15,436	1,932 Added 43.56%	6,367 $43,000
Q4 2022 Feb 10, 2023	SELL	$6.87 - $10.96 $2,541 - $4,055	-370 Reduced 7.7%	4,435 $32,000
Q3 2022 Nov 14, 2022	SELL	$9.44 - $11.76 $6,891 - $8,584	-730 Reduced 13.19%	4,805 $47,000
Q2 2022 Aug 10, 2022	BUY	$9.31 - $11.84 $1,508 - $1,918	162 Added 3.02%	5,535 $60,000
Q1 2022 May 04, 2022	BUY	$10.84 - $16.55 $10,850 - $16,566	1,001 Added 22.9%	5,373 $62,000
Q3 2021 Nov 05, 2021	BUY	$15.35 - $21.27 $460 - $638	30 Added 0.69%	4,372 $74,000
Q2 2021 Aug 02, 2021	BUY	$15.71 - $21.51 $8,216 - $11,249	523 Added 13.69%	4,342 $93,000
Q1 2021 May 13, 2021	BUY	$13.42 - $20.28 $6,267 - $9,470	467 Added 13.93%	3,819 $58,000
Q4 2020 Feb 10, 2021	BUY	$9.77 - $13.81 $6,116 - $8,645	626 Added 22.96%	3,352 $44,000
Q3 2020 Nov 12, 2020	SELL	$9.32 - $12.02 $9,375 - $12,092	-1,006 Reduced 26.96%	2,726 $29,000
Q2 2020 Aug 14, 2020	BUY	$9.66 - $12.02 $10,838 - $13,486	1,122 Added 42.99%	3,732 $43,000
Q1 2020 May 18, 2020	BUY	$7.5 - $16.8 $19,575 - $43,848	2,610 New	2,610 $28,000

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $247M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Vanda Pharmaceuticals Inc. Transaction History